New Pain Drug Gets Fast Tracked

20:00 EDT 7 Aug 2017 | JAMA

In June, the US Food and Drug Administration (FDA) granted fast-track designation to drug makers Pfizer and Eli Lilly for tanezumab, an investigational treatment for chronic pain in patients with osteoarthritis and chronic low back pain.

Original Article: New Pain Drug Gets Fast Tracked


More From BioPortfolio on "New Pain Drug Gets Fast Tracked"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...